Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
How did VTRS's recent EPS compare to expectations?
The most recent EPS for Viatris Inc is $0.56, beating expectations of $0.54.
How did Viatris Inc VTRS's revenue perform in the last quarter?
Viatris Inc revenue for the last quarter is $0.56
What is the revenue estimate for Viatris Inc?
According to 10 of Wall street analyst, the revenue estimate of Viatris Inc range from $3.86B to $3.56B
What's the earning quality score for Viatris Inc?
Viatris Inc has a earning quality score of A-/58.83025. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Viatris Inc report earnings?
Viatris Inc next earnings report is expected in 2026-05-27
What are Viatris Inc's expected earnings?
Viatris Inc expected earnings is $3.6B, according to wall-street analysts.
Did Viatris Inc beat earnings expectations?
Viatris Inc recent earnings of $3.7B beat expectations.